State of the Industry 2011: Introduction
Managed Healthcare Executive recently surveyed readers and gathered your predictions for the industry's dramatically changing future
Overall, readers are more pessimistic about the future than in State of the Industry surveys of the past, but much of the pessimism stems from uncertainty. Even though PPACA was signed into law in March, the secretary of Health and Human Services has hundreds of decisions to carry out that will require years of groundwork and far-reaching collaborative efforts with the private sector. For many logistical points, healthcare leaders must simply wait and see. However, once guidance for each PPACA measure is issued, implementation becomes a sudden race against the clock.
Nearly 650 readers completed the 2011 State of the Industry survey via an electronic invitation, including health plans, providers, consultants, administrative firms, pharmacy benefit managers, disease management companies and employers.
Differences in Defining “Clinically Meaningful” in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis
October 4th 2024Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the symptoms, epidemiology diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) in a Managed Healthcare Executive K-Cast video series.
Read More
